Literature DB >> 31974637

Quantitative Muscle MRI Protocol as Possible Biomarker in Becker Muscular Dystrophy.

Lorenzo Maggi1,2, Marco Moscatelli3, Rita Frangiamore4, Federica Mazzi3, Mattia Verri3, Alberto De Luca5, Maria Barbara Pasanisi4, Giovanni Baranello6, Irene Tramacere7, Luisa Chiapparini3, Maria Grazia Bruzzone3, Renato Mantegazza4, Domenico Aquino3.   

Abstract

PURPOSE: Aim of this study is to compare Quantitative Magnetic Resonance Imaging (qMRI) measures between Becker Muscular Dystrophy (BMD) and Healthy Subjects (HS) and to correlate these parameters with clinical scores.
METHODS: Ten BMD patients (mean age ±standard deviation: 38.7 ± 15.0 years) and ten age-matched HS, were investigated through magnetic resonance imaging (MRI) at thigh and calf levels, including: 1) a standard axial T1-weighted sequence; 2) a volumetric T2-weighted sequence; 3) a multiecho spin-echo sequence; 4) a 2-point Dixon sequence; 5) a Diffusion Tensor Imaging (DTI) sequence.
RESULTS: Mean Fat Fraction (FF), T2-relaxation time and Fractional Anisotropy (FA) DTI at thigh and calf levels were significantly higher in BMD patients than in HS (p-values < 0.01). FF at thigh and calf levels significantly correlated with North Star Ambulatory Assessment (NSAA) score (p-values < 0.01) and6 Minutes Walking Test (6MWT) (p-values < 0.01), whereas only calf muscle FF was significantly associated with time to get up from floor (p-value = 0.01). T2 significantly correlated with NSAA score (p-value < 0.01), 6MWT (p-value = 0.02) and time to get up from floor (p-value < 0.01) only at calf level. Among DTI values, only FA in thigh and calf muscles significantly correlated with NSAA score, 6MWT and 10-m walk (all p-values < 0.05); only FA in calf muscles significantly correlated with time to get up from floor (p = 0.01).
CONCLUSIONS: Muscle FF, T2-relaxometry and DTI, seem to be a promising biomarker to assess BMD disease severity, although further studies are needed to evaluate changes over the time.

Entities:  

Keywords:  Becker muscular dystrophy; Diffusion tensor imaging; Fat fraction; T2 relaxometry; qMRI

Year:  2020        PMID: 31974637     DOI: 10.1007/s00062-019-00875-0

Source DB:  PubMed          Journal:  Clin Neuroradiol        ISSN: 1869-1439            Impact factor:   3.649


  37 in total

1.  Muscle fat-fraction and mapping in Duchenne muscular dystrophy: evaluation of disease distribution and correlation with clinical assessments. Preliminary experience.

Authors:  Michele Gaeta; Sonia Messina; Achille Mileto; Gian Luca Vita; Giorgio Ascenti; Sergio Vinci; Antonio Bottari; Giuseppe Vita; Nicola Settineri; Daniele Bruschetta; Sergio Racchiusa; Fabio Minutoli
Journal:  Skeletal Radiol       Date:  2011-11-10       Impact factor: 2.199

2.  Quantitative MRI can detect subclinical disease progression in muscular dystrophy.

Authors:  Arne Fischmann; Patricia Hafner; Susanne Fasler; Monika Gloor; Oliver Bieri; Ueli Studler; Dirk Fischer
Journal:  J Neurol       Date:  2012-08       Impact factor: 4.849

3.  Quantitative muscle MRI: A powerful surrogate outcome measure in Duchenne muscular dystrophy.

Authors:  Ulrike Bonati; Patricia Hafner; Sabine Schädelin; Maurice Schmid; Arjith Naduvilekoot Devasia; Jonas Schroeder; Stephanie Zuesli; Urs Pohlman; Cornelia Neuhaus; Andrea Klein; Michael Sinnreich; Tanja Haas; Monika Gloor; Oliver Bieri; Arne Fischmann; Dirk Fischer
Journal:  Neuromuscul Disord       Date:  2015-06-04       Impact factor: 4.296

4.  Muscle fat fraction in neuromuscular disorders: dual-echo dual-flip-angle spoiled gradient-recalled MR imaging technique for quantification--a feasibility study.

Authors:  Michele Gaeta; Emanuele Scribano; Achille Mileto; Silvio Mazziotti; Carmelo Rodolico; Antonio Toscano; Nicola Settineri; Giorgio Ascenti; Alfredo Blandino
Journal:  Radiology       Date:  2011-01-28       Impact factor: 11.105

5.  Examination of effects of corticosteroids on skeletal muscles of boys with DMD using MRI and MRS.

Authors:  Ishu Arpan; Rebecca J Willcocks; Sean C Forbes; Richard S Finkel; Donovan J Lott; William D Rooney; William T Triplett; Claudia R Senesac; Michael J Daniels; Barry J Byrne; Erika L Finanger; Barry S Russman; Dah-Jyuu Wang; Gihan I Tennekoon; Glenn A Walter; H L Sweeney; Krista Vandenborne
Journal:  Neurology       Date:  2014-08-06       Impact factor: 9.910

6.  The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy. I. Natural history.

Authors:  K M Bushby; D Gardner-Medwin
Journal:  J Neurol       Date:  1993-02       Impact factor: 4.849

7.  The TREAT-NMD Duchenne muscular dystrophy registries: conception, design, and utilization by industry and academia.

Authors:  Catherine L Bladen; Karen Rafferty; Volker Straub; Soledad Monges; Angélica Moresco; Hugh Dawkins; Anna Roy; Teodora Chamova; Velina Guergueltcheva; Lawrence Korngut; Craig Campbell; Yi Dai; Nina Barišić; Tea Kos; Petr Brabec; Jes Rahbek; Jaana Lahdetie; Sylvie Tuffery-Giraud; Mireille Claustres; France Leturcq; Rabah Ben Yaou; Maggie C Walter; Olivia Schreiber; Veronika Karcagi; Agnes Herczegfalvi; Venkatarman Viswanathan; Farhad Bayat; Isis de la Caridad Guerrero Sarmiento; Anna Ambrosini; Francesca Ceradini; En Kimura; Janneke C van den Bergen; Miriam Rodrigues; Richard Roxburgh; Anna Lusakowska; Jorge Oliveira; Rosário Santos; Elena Neagu; Niculina Butoianu; Svetlana Artemieva; Vedrana Milic Rasic; Manuel Posada; Francesc Palau; Björn Lindvall; Clemens Bloetzer; Ayşe Karaduman; Haluk Topaloğlu; Serap Inal; Piraye Oflazer; Angela Stringer; Andriy V Shatillo; Ann S Martin; Holly Peay; Kevin M Flanigan; David Salgado; Brigitta von Rekowski; Stephen Lynn; Emma Heslop; Sabina Gainotti; Domenica Taruscio; Jan Kirschner; Jan Verschuuren; Kate Bushby; Christophe Béroud; Hanns Lochmüller
Journal:  Hum Mutat       Date:  2013-08-26       Impact factor: 4.878

8.  Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies.

Authors:  A H Beggs; E P Hoffman; J R Snyder; K Arahata; L Specht; F Shapiro; C Angelini; H Sugita; L M Kunkel
Journal:  Am J Hum Genet       Date:  1991-07       Impact factor: 11.025

9.  Clinical variability in Becker muscular dystrophy. Genetic, biochemical and immunohistochemical correlates.

Authors:  G P Comi; A Prelle; N Bresolin; M Moggio; A Bardoni; A Gallanti; G Vita; A Toscano; M T Ferro; A Bordoni
Journal:  Brain       Date:  1994-02       Impact factor: 13.501

10.  MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study.

Authors:  Jasper M Morrow; Christopher D J Sinclair; Arne Fischmann; Pedro M Machado; Mary M Reilly; Tarek A Yousry; John S Thornton; Michael G Hanna
Journal:  Lancet Neurol       Date:  2015-11-06       Impact factor: 44.182

View more
  5 in total

1.  Quantitative muscle MRI as a sensitive marker of early muscle pathology in myotonic dystrophy type 1.

Authors:  Ellen van der Plas; Laurie Gutmann; Dan Thedens; Richard K Shields; Kathleen Langbehn; Zhihui Guo; Milan Sonka; Peggy Nopoulos
Journal:  Muscle Nerve       Date:  2021-02-05       Impact factor: 3.217

2.  Novel Muscle Imaging in Inflammatory Rheumatic Diseases-A Focus on Ultrasound Shear Wave Elastography and Quantitative MRI.

Authors:  Matthew Farrow; John Biglands; Abdulrahman M Alfuraih; Richard J Wakefield; Ai Lyn Tan
Journal:  Front Med (Lausanne)       Date:  2020-08-12

3.  Patients With Becker Muscular Dystrophy Have Severe Paraspinal Muscle Involvement.

Authors:  Aisha M Sheikh; Karen Rudolf; Josefine de Stricker Borch; Tahmina Khawajazada; Nanna Witting; John Vissing
Journal:  Front Neurol       Date:  2021-05-21       Impact factor: 4.003

4.  Supervised segmentation framework for evaluation of diffusion tensor imaging indices in skeletal muscle.

Authors:  Laura Secondulfo; Augustin C Ogier; Jithsa R Monte; Vincent L Aengevaeren; David Bendahan; Aart J Nederveen; Gustav J Strijkers; Melissa T Hooijmans
Journal:  NMR Biomed       Date:  2020-10-01       Impact factor: 4.044

5.  Selection Approach to Identify the Optimal Biomarker Using Quantitative Muscle MRI and Functional Assessments in Becker Muscular Dystrophy.

Authors:  Nienke M van de Velde; Melissa T Hooijmans; Aashley S D Sardjoe Mishre; Kevin R Keene; Zaïda Koeks; Thom T J Veeger; Iris Alleman; Erik W van Zwet; Jan-Willem M Beenakker; Jan J G M Verschuuren; Hermien E Kan; Erik H Niks
Journal:  Neurology       Date:  2021-06-23       Impact factor: 9.910

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.